Document is current
Any future updates will be listed below
-
Authors
Blanc, Jérémy https://orcid.org/0009-0008-0056-7898
Carnot, Aurélien
Barthélémy, Philippe
Casert, Vinciane
Sautois, Brieuc
Van den Brande, Jan
Vanhaudenarde, Vincent
Staudacher, Lionel
Seront, Emmanuel
Debien, Veronique
Ameye, Lieveke https://orcid.org/0000-0001-5153-1766
Kotecki, Nuria
Rothé, Françoise
Rorive, Sandrine
Fantoni, Jean-Christophe
Tricard, Thibault
Roumeguère, Thierry
Awada, Ahmad
Martinez Chanza, Nieves
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03674424 at ClinicalTrials.govnct03674424 at ClinicalTrials.govDocuments that mention this clinical trial
Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial
https://doi.org/10.1136/jitc-2025-012045
Avelumab (A) as neoadjuvant therapy in patients (pts) with muscle-invasive urothelial carcinoma (MIUC): Survival data of AURA trial, Oncodistinct 004.
https://doi.org/10.1200/jco.2024.42.16_suppl.4516
nct03674424 at ClinicalTrials.govDocuments that mention this clinical trial
Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial
https://doi.org/10.1136/jitc-2025-012045
Avelumab (A) as neoadjuvant therapy in patients (pts) with muscle-invasive urothelial carcinoma (MIUC): Survival data of AURA trial, Oncodistinct 004.
https://doi.org/10.1200/jco.2024.42.16_suppl.4516
Documents that mention this clinical trial
Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial
https://doi.org/10.1136/jitc-2025-012045
Avelumab (A) as neoadjuvant therapy in patients (pts) with muscle-invasive urothelial carcinoma (MIUC): Survival data of AURA trial, Oncodistinct 004.
https://doi.org/10.1200/jco.2024.42.16_suppl.4516
-
Funding
Funding for this research was provided by:
Association Jules Bordet (N/A)
Merck Healthcare KGaA (N/A)
Institut Jules Bordet (Sponsor)
- License Information
